Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Maternity
  4. Back
  5. Common obstetric problems, intrapartum labour ward
  6. Fetal Blood Sampling in Labour (627)

Fetal Blood Sampling in Labour (627)

Warning

Please report any inaccuracies or issues with this guideline using our online form

Foreword on Updated Guidance: Fetal Blood Sampling (May 2025)

Guidance from ‘Fetal monitoring in labour, NICE guideline [NG229] Published: 14 December 2022’ is as follows (1) :

1.7 Fetal blood sampling

1.7.1 NICE is unable to make a recommendation about fetal blood sampling because of limited evidence. [2022]

Recent recommendations from NICE have suggested the removal of existing guidance advising the use of fetal blood sampling in assessment of fetal wellbeing in labour (2).

Reference is made to recent guidance from NICE on Fetal Monitoring in Labour; Evidence review for fetal blood sampling’. The committee reviewed data comparing FBS to no FBS with or without CTG, and to digital fetal scalp stimulation (dFSS).

The evidence showed no important difference for most neonatal outcomes, with the exception of Apgar score <7 where FBS with CTG showed an important harm, compared to CTG alone. This was possibly due to delay in expediting birth, to allow the FBS to be carried out. When compared to dFSS with CTG, FBS with CTG showed an increase in caesarean births. The committee were unable to define whether this outcome was harmful or a benefit.

Quality of evidence ranged from very low to moderate and so experiential knowledge was taken into account when considering other disadvantages to FBS, including injury to baby, delay in expediting birth and maternal discomfort and anxiety. dFSS was agreed to be less invasive, required less time and was more acceptable to women in terms of their overall experience in labour. They clarified that dFSS should be used in conjunction with an assessment of other risk factors.

In conclusion, the committee supports the decision to no longer recommend FBS as a tool for assessing fetal wellbeing. Existing recommendations advising the use of FBS have been removed. They authors made reference to the ‘FIRSST’ study (Fetal Intrapartum Randomised Scalp Stimulation Trial).

FIRSST has since published in January 2025 (3). The authors concluded that they were unable to determine whether dFSS performs better as a second line test of fetal well-being in labour than FBS.

Main points to note:

1. The main limitation of the trial was the inability to match randomisation rates achieved in the pilot study, leading to the decision to close the study early. Therefore, the trial was insufficiently powered to draw conclusions on whether dFSS performed better than FBS as a second line test of fetal well-being in labour.

2. Data from non-randomised participants demonstrated a clinical preference for dFSS. The circulation of the aforementioned draft NICE guidance advising against the use of FBS in labour to assess fetal wellbeing, shortly after initiation of the trial, was felt to be an important contributing factor to this.

FIRSST suggests that further high-quality data on use of both dFSS and FBS is required to guide assessment of fetal wellbeing in labour. NICE have not made further recommendations following publication of the trial.

Guidance from the previous document (2017 NICE guideline) has been included below to provide advice on performing FBS, should the treating clinician feel it is required in a clinical scenario. NICE have not released any new guidance to supersede this (4).

1. Yambasu S, Boland F, O’Donoghue K, Curran C, Shahabuddin Y, Cotter A, et al. Digital Foetal Scalp Stimulation Versus Foetal Blood Sampling to Assess Foetal Well-Being in Labour: A Multicentre Randomised Controlled Trial. BJOG. 2025 Apr 1;

2. NICE. Fetal monitoring in labour guideline [NG 229]. 2022.

3. NICE. Fetal Blood Sampling in Labour evidence review to underpin recommendation 1.7.1 in the NICE Fetal monitoring in labour guideline. 2022.

4. NICE. Intrapartum care NICE guideline [NG 235]. 2023. Available from: www.nice.org.uk/guidance/ng235

Definition

Fetal blood sample (FBS) refers to obtaining a sample of blood from the presenting part of the baby in utero, during labour. It is used to measure fetal pH or lactate as a way of identifying hypoxaemia and acidosis and stratifying those who require urgent delivery.

Acidosis reflects fetal hypoxaemia as when hypoxic, fetal metabolism changes from aerobic to anaerobic which results in the production of lactic acid. This leads to a subsequent drop in fetal pH and provides a measure of the degree of hypoxaemia for the baby in labour.

Indications

The indications for FBS include:

  • pathological CTG in labour (cervix dilated >3 cm, membranes ruptured)

Pre-requisites

Before you start an FBS procedure, you must:

  • Start conservative measures and offer digital fetal scalp stimulation. Only continue with fetal blood sampling if the CTG trace remains pathological.

  • Confirm the position and dilatation of the cervix (>3 cm), station of the presenting part and ensure membranes are ruptured.

  • Explain the procedure to the woman and obtain her verbal consent (see below).

  • Ensure that the instruments are to hand and that the blood gas analyser is functioning.

  • Ensure there are no contraindications for the procedure.

Contraindications

The contraindications include:

  • An acute event, for example, cord prolapse, suspected placental abruption or suspected uterine rupture.
  • Acute fetal compromise as suggested by a prolonged ongoing fetal bradycardia of >3 minutes.
  • Risk of maternal- fetal infection transfer, for example maternal HIV, maternal hepatitis viruses or active herpes simplex virus.
  • Fetal bleeding disorders or suspected fetal bleeding disorders, for example haemophilia, maternal thrombocytopenia.
  • Prematurity, less than 34 weeks gestation (i.e. <34+0 weeks).
  • Face presentation.
  • The whole clinical picture indicates that the birth should be expedited, for example maternal sepsis, unstable pre-eclampsia.
  • Do not take a sample immediately following a prolonged deceleration.

Cautions

Be aware that for women with sepsis or significant meconium, fetal blood sampling results may be falsely reassuring. 

Obtaining consent

NICE guidelines 2017 recommend that when considering fetal blood sampling, explain the following to the woman and her birth companion(s):

  • Why the test is being considered and other options available, including the risks, benefits and limitations of each.
  • The blood sample will be used to measure the level of acid in the baby's blood, which may help to show how well the baby is coping with labour.
  • The procedure will require her to have a vaginal examination using a device similar to a speculum.
  • A sample of blood will be taken from the baby's head by making a small scratch on the baby's scalp. This will heal quickly after birth, but there is a small risk of infection.
  • What the different outcomes of the test may be (normal, borderline and abnormal) and the actions that will follow each result.
  • If a FBS cannot be obtained but there are fetal heart rate accelerations in response to the procedure, this is encouraging and in these circumstances expediting the birth may not be necessary.
  • If a FBS cannot be obtained and the cardiotocograph trace has not improved, expediting the birth will be advised.
  • A caesarean section or instrumental birth (forceps or ventouse) may be advised, depending on the results of the procedure.

Equipment

The sterile FBS pack contains as standard the following:

Sponge holder,  Amnioscope with attachable light source, 2 blades with blade holder, 5 capillary tubes and capillary tube holder, petroleum jelly, 6 large cotton swabs and 5 square green swabs.

In addition you will need

  • Lubricant gel –do not use Hibitane as this may alter the pH results
  • Ethyl chloride spray
  • Water for washing
  • Sterile gloves
  • Apron

Procedure

  • Ensure Labour Ward co-ordinator is aware you are undertaking this test prior to starting and ensure the blood gas analyser is ready to be used.
  • Place the woman either in a lithotomy or left lateral position with her right leg supported and abducted. Then drape the area around the perineum to provide a clean field.
  • Introduce the lubricated amnioscope. Direct the amnioscope posteriorly and sweep it anteriorly to catch the anterior lip of the cervix.
  • Remove the amnioscope’s obturator. Ideally, the cervix should not be visible. Try to visualise the fetal scalp clearly.
  • Clean the fetal scalp with a cotton wool swab, contamination with liquor or meconium can affect results. Spray the scalp with ethyl chloride to produce a reactive hyperaemia.
  • Apply a thin film of petroleum jelly with one of the large cotton wool swabs to increase surface tension on the fetal scalp; this encourages the formation of droplets of blood.
  • Insert the blade provided in the pack into the scalp to the full depth of the guard. Do not stroke the blade across the scalp as this may produce a lesion that is too large.
  • Collect the blood droplet into your capillary tube. At least two samples should be obtained. The second may be taken while the first is being analysed by an assistant.
  • Apply pressure to the fetal scalp with cotton wool swab at the end of the procedure if any bleeding is evident.
  • Reposition the mother comfortably and explain the results to her with your action plan.

Interpretation of results

A flow diagram for the interpretation of both pH and lactate is included at the end of this document.

pH rather than lactate is currently used within GGC for interpretation of fetal blood sampling, but please make sure you adhere to your local hospital policy.

The results should be interpreted taking into account the previous pH or lactate measurement, the rate of progress in labour and the clinical features of the woman and baby.

Where a FBS is indicated but a sample cannot be obtained and there is no improvement in the cardiotocograph trace, advise the woman that the birth should be expedited.

When planning to repeat an FBS, the time taken to obtain a sample must be taken into account

Post Delivery

If FBS is undertaken during labour, ensure paired cord gases are obtained at delivery and documented in the notes.

Fetal blood sampling flowchart

Editorial Information

Last reviewed: 06/05/2025

Next review date: 31/05/2028

Author(s): Dawn Kernaghan.

Version: 3

Author email(s): Dawn.Kernaghan2@nhs.scot.

Approved By: Maternity Clinical Governance Group

Document Id: 627

References

StratOG eLearning module, Fetal Blood Sampling, 2015, https://stratog.rcog.org.uk/tutorial/obstetrics/fetal-blood-sampling-5811

Intrapartum Care for healthy women and their babies, Clinical guideline [CG190], December 2014, updated  February 2017, https://www.nice.org.uk/guidance/cg190/chapter/Recommendations#monitoring-during-labour

RCOG Scientific Impact Paper No. 47, Is it time for UK obstetricians to accept Fetal Scalp lactate as an alternative to Fetal Scalp pH?  January 2015 https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_47.pdf